Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Astrazeneca, Biontech, Cansino, Carsgen, Gannex, GC, Harbour Biomed, Iaso, Idorsia, Innovent, Johnson & Johnson, Pfizer, Qurebio, RDIF, Regeneron, Roche, Sciwind, Very, Wuhan Institute of Biological Products.